Rieber M, Gross A, Rieber M S
Cancer Res. 1987 Oct 1;47(19):5127-31.
Primary melanocytes attach poorly to collagen type IV and laminin, in contrast to their firm attachment to collagen type I/III and fibronectin [Gilchrest et al., In vitro (Rockville), 21: 114-120, 1985]. We have now found that metastatic B16 melanoma cells attach well to collagen type IV, laminin, vitronectin, and fibronectin but show a selective defect in attachment and cell aggregation on native collagen type I. Both flattened and aggregated melanoma cells revealed the presence of a Mr 120,000 surface-iodinated species with affinity for a matrix containing the hexapeptide (glycylarginylglycylaspartylserylproline) which includes the fibronectin cell attachment sequence, but only flattened cells showed significant exposure of a Mr 140,000 iodinated component with affinity for a large cell attachment-promoting fibronectin polypeptide. Decrease of the Mr 140,000 fibronectin-binding external protein in the collagen-cultured melanoma cells was also associated with an inability to respond to the cell attachment activity of fibronectin, laminin, or vitronectin added to the collagen gels. Metabolic labeling with [3H]glucosamine and electrophoretic analysis showed that lack of attachment and cell aggregation was associated with an increase in high molecular weight wheat germ agglutinin-binding glycoconjugates and an increase in Mr 55,000 concanavalin A-binding glycoprotein species. Our data suggest that: (a) melanoma cell attachment requires the expression of the Mr 140,000 fibronectin receptor which appears to be down regulated in cells exposed to poorly adhesive substrates; (b) expression of the Mr 120,000 iodinated species with affinity for the fibronectin attachment sequence (arginylglycylaspartic acid) may be necessary but not sufficient for firm cell-substratum interactions; (c) increased tumor cell-cell interaction may involve a decreased attachment to substrate and the expression of different glycoproteins which may modulate cell-cell association.
与原代黑素细胞能牢固附着于I/III型胶原蛋白和纤连蛋白不同,它们很难附着于IV型胶原蛋白和层粘连蛋白[吉尔克里斯特等人,《体外研究》(罗克维尔),21: 114 - 120,1985年]。我们现在发现,转移性B16黑色素瘤细胞能很好地附着于IV型胶原蛋白、层粘连蛋白、玻连蛋白和纤连蛋白,但在天然I型胶原蛋白上的附着和细胞聚集存在选择性缺陷。扁平状和聚集状的黑色素瘤细胞均显示存在一种分子量为120,000的表面碘化物种,它对含有六肽(甘氨酰 - 精氨酰 - 甘氨酰 - 天冬氨酰 - 丝氨酰 - 脯氨酸)的基质具有亲和力,该六肽包含纤连蛋白的细胞附着序列,但只有扁平状细胞显示出一种分子量为140,000的碘化成分有显著暴露,它对一种促进细胞附着的大型纤连蛋白多肽具有亲和力。在胶原蛋白培养的黑色素瘤细胞中,分子量为140,000的纤连蛋白结合性外部蛋白的减少也与无法对添加到胶原蛋白凝胶中的纤连蛋白、层粘连蛋白或玻连蛋白的细胞附着活性作出反应有关。用[³H]葡糖胺进行代谢标记并通过电泳分析表明,缺乏附着和细胞聚集与高分子量麦胚凝集素结合糖缀合物的增加以及分子量为55,000的伴刀豆球蛋白A结合糖蛋白物种的增加有关。我们的数据表明:(a) 黑色素瘤细胞的附着需要分子量为140,000的纤连蛋白受体的表达,在暴露于低粘附性底物的细胞中,该受体似乎被下调;(b) 对纤连蛋白附着序列(精氨酰 - 甘氨酰 - 天冬氨酸)具有亲和力的分子量为120,000的碘化物种的表达对于牢固的细胞 - 基质相互作用可能是必要的,但并不充分;(c) 肿瘤细胞 - 细胞相互作用的增加可能涉及对底物附着的减少以及不同糖蛋白的表达,这些糖蛋白可能调节细胞 - 细胞关联。